BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18478553)

  • 1. Virus-induced alterations of membrane lipids affect the incorporation of PrP Sc into cells.
    Avrahami D; Dayan-Amouyal Y; Tal S; Mincberg M; Davis C; Abramsky O; Gabizon R
    J Neurosci Res; 2008 Sep; 86(12):2753-62. PubMed ID: 18478553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
    Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
    Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation.
    Iwamaru Y; Shimizu Y; Imamura M; Murayama Y; Endo R; Tagawa Y; Ushiki-Kaku Y; Takenouchi T; Kitani H; Mohri S; Yokoyama T; Okada H
    J Neurochem; 2008 Nov; 107(3):636-46. PubMed ID: 18717818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.
    Haviv Y; Avrahami D; Ovadia H; Ben-Hur T; Gabizon R; Sharon R
    Arch Neurol; 2008 Jun; 65(6):762-75. PubMed ID: 18541796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of glypican-1 autoprocessing in scrapie infection.
    Löfgren K; Cheng F; Fransson LA; Bedecs K; Mani K
    Eur J Neurosci; 2008 Sep; 28(5):964-72. PubMed ID: 18717736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines.
    Pimpinelli F; Lehmann S; Maridonneau-Parini I
    Eur J Neurosci; 2005 Apr; 21(8):2063-72. PubMed ID: 15869502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
    Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
    J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Fenton reaction on protease-resistant prion protein (PrPSc) degradation and scrapie infectivity.
    Park SJ; Kim NH; Jeong BH; Jin JK; Choi JK; Park YJ; Kim JI; Carp RI; Kim YS
    Brain Res; 2008 Oct; 1238():172-80. PubMed ID: 18771660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups.
    Lucassen R; Nishina K; Supattapone S
    Biochemistry; 2003 Apr; 42(14):4127-35. PubMed ID: 12680767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection route-independent accumulation of splenic abnormal prion protein.
    Inoue Y; Yamakawa Y; Sakudo A; Kinumi T; Nakamura Y; Matsumoto Y; Saeki K; Kamiyama T; Onodera T; Nishijima M
    Jpn J Infect Dis; 2005 Apr; 58(2):78-82. PubMed ID: 15858284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy.
    Heiseke A; Aguib Y; Riemer C; Baier M; Schätzl HM
    J Neurochem; 2009 Apr; 109(1):25-34. PubMed ID: 19183256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
    Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
    Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic fibril peptide promotes clearance of scrapie prion protein by lysosomal degradation.
    Okemoto-Nakamura Y; Yamakawa Y; Hanada K; Tanaka K; Miura M; Tanida I; Nishijima M; Hagiwara K
    Microbiol Immunol; 2008 Jul; 52(7):357-65. PubMed ID: 18667034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation.
    Gilch S; Nunziante M; Ertmer A; Schätzl HM
    Vet Microbiol; 2007 Aug; 123(4):377-86. PubMed ID: 17493775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolism of glycosaminoglycans is impaired in prion diseases.
    Mayer-Sonnenfeld T; Zeigler M; Halimi M; Dayan Y; Herzog C; Lasmezas CI; Gabizon R
    Neurobiol Dis; 2005 Dec; 20(3):738-43. PubMed ID: 15951190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
    Uppington KM; Brown DR
    J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
    Piening N; Weber P; Giese A; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PrPSc level and incubation time in a transgenic mouse model expressing Borna disease virus phosphoprotein after intracerebral prion infection.
    Sakudo A; Onodera T; Ikuta K
    Neurosci Lett; 2008 Jan; 431(1):81-5. PubMed ID: 18155836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.